Vertex Pharmaceutica
VRTX
Delayed Nasdaq - 08/22 10:00:00 pm
155.48USD
+4.34%
Upcoming events
10/31/17
Q3 2017 Earnings Release (Projected)
01/31/18
FY 2017 Earnings Release (Projected)
Past Events
08/08/17MUFG Securities Seattle Investor Conference
07/26/17 | 11:15pmInterim 2017 Earnings Call
07/26/17 | 10:01pmInterim 2017 Earnings Release
07/18/17 | 11:00pmBusiness Update Call
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
1 701
1 696
0,30%

2 280
Operating income (EBITDA)
Million $
Released
Forecast
Spread
350
329
6,2%

467
Operating profit (EBIT)
Million $
Released
Forecast
Spread
288
242
19%

484
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-112
-133
16%

182
EPS
 $
Released
Forecast
Spread
-0,46
-0,46
-0,94%

0,69
Announcement Date01/25/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
544
487
12%

515
Operating income (EBITDA)
Million $
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
112
88,8
27%

79,8
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
18,0
13,4
34%

-97,8
EPS
 $
Released
Forecast
Spread
0,07
0,07
-4,2%

-0,45
Announcement Date07/26/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise